San Diego, California–(Newsfile Corp. – August 18, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company”), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today the appointment of Dennis Langer, M.D., J.D., as Senior Advisor to the Company. Dr. Langer has been a Director, Co-Founder…


Previous articleHow PCP Became A Weapon of Police Propaganda [Part 2]
Next articleWesana Health Highlights Recent Appointments to Board of Directors